NO20082105L - Pyrazoloisokinolinderivater - Google Patents

Pyrazoloisokinolinderivater

Info

Publication number
NO20082105L
NO20082105L NO20082105A NO20082105A NO20082105L NO 20082105 L NO20082105 L NO 20082105L NO 20082105 A NO20082105 A NO 20082105A NO 20082105 A NO20082105 A NO 20082105A NO 20082105 L NO20082105 L NO 20082105L
Authority
NO
Norway
Prior art keywords
pyrazoloisokinolinderivater
compounds
meanings
useful
formula
Prior art date
Application number
NO20082105A
Other languages
English (en)
Inventor
Marina Virgili Bernado
Carmen Almansa Rosales
Original Assignee
Palau Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Palau Pharma Sa filed Critical Palau Pharma Sa
Publication of NO20082105L publication Critical patent/NO20082105L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Nye forbindelser med formel I, hvor betydningene for de forskjellige substituenter er som beskrevet i beskrivelsen. Disse forbindelser er anvendelige som p38-kinaseinhibitorer.
NO20082105A 2005-11-25 2008-05-06 Pyrazoloisokinolinderivater NO20082105L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05381056 2005-11-25
PCT/EP2006/068815 WO2007060198A1 (en) 2005-11-25 2006-11-23 Pyrazoloisoquinoline derivatives

Publications (1)

Publication Number Publication Date
NO20082105L true NO20082105L (no) 2008-07-31

Family

ID=37672381

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20082105A NO20082105L (no) 2005-11-25 2008-05-06 Pyrazoloisokinolinderivater

Country Status (15)

Country Link
US (1) US20080269209A1 (no)
EP (1) EP1960400A1 (no)
JP (1) JP2009517367A (no)
KR (1) KR20080070687A (no)
CN (1) CN101312974A (no)
AR (1) AR058223A1 (no)
AU (1) AU2006316435A1 (no)
BR (1) BRPI0618976A2 (no)
CA (1) CA2630907A1 (no)
IL (1) IL191138A0 (no)
NO (1) NO20082105L (no)
PE (1) PE20071086A1 (no)
RU (1) RU2008125858A (no)
TW (1) TW200804375A (no)
WO (1) WO2007060198A1 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008001932A1 (de) 2008-05-21 2009-11-26 Bayer Cropscience Ag Substiuierte Spiroisoxazoline
FR2944792B1 (fr) * 2009-04-24 2011-05-20 Sanofi Aventis Derives de 1h-pyrazolo[4,3-c]isoquinoleines, leur preparation et leur application en therapeutique
EP3640251B1 (en) 2016-10-24 2021-12-08 Astrazeneca AB 6,7,8,9-tetrahydro-3h-pyrazolo[4,3-f]isoquinoline derivatives useful in the treatment of cancer
PL3494116T3 (pl) 2017-01-30 2020-04-30 Astrazeneca Ab Modulatory receptora estrogenowego
US12570670B2 (en) 2019-01-30 2026-03-10 Yale University Compounds, compositions, and methods for treating fibrosis
MX2022013391A (es) 2020-04-24 2022-11-30 Astrazeneca Ab Pauta posologica para el tratamiento del cancer.
MX2022013258A (es) 2020-04-24 2022-11-14 Astrazeneca Ab Formulaciones farmaceuticas.
CN113877483B (zh) * 2021-07-20 2023-11-24 烟台宁远药业有限公司 医药中间体卤代异喹啉类硼酸的低温连续合成装置与方法
CN115894146B (zh) * 2022-11-24 2025-05-06 上海固创化工新材料有限公司 一种3-溴-1-苯基萘的合成方法
CN120365270A (zh) * 2024-01-23 2025-07-25 杭州中美华东制药有限公司 具有pkmyt1抑制作用的化合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5696143A (en) * 1994-09-20 1997-12-09 Talley; John J. Benz G! indazolyl derivatives for the treatment of inflammation
ATE415162T1 (de) * 2001-06-11 2008-12-15 Vertex Pharma Isochinolin-inhibitoren von p38
WO2003027075A2 (en) * 2001-09-19 2003-04-03 Pharmacia Corporation Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation
US20050176796A1 (en) * 2002-02-19 2005-08-11 D'alessio Roberto Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents
EP1644371B1 (en) * 2003-07-03 2008-02-13 Aventis Pharmaceuticals Inc. Pyrazoloisoquinoline derivatives as kinase inhibitors
EP1648455A4 (en) * 2003-07-23 2009-03-04 Exelixis Inc MODULATORS OF ALK PROTEIN (ANAPLASTIC LYMPHOMA KINASE) AND METHODS OF USE

Also Published As

Publication number Publication date
JP2009517367A (ja) 2009-04-30
CA2630907A1 (en) 2007-05-31
AR058223A1 (es) 2008-01-23
US20080269209A1 (en) 2008-10-30
CN101312974A (zh) 2008-11-26
EP1960400A1 (en) 2008-08-27
BRPI0618976A2 (pt) 2011-09-20
PE20071086A1 (es) 2007-11-19
IL191138A0 (en) 2008-12-29
WO2007060198A1 (en) 2007-05-31
KR20080070687A (ko) 2008-07-30
AU2006316435A1 (en) 2007-05-31
RU2008125858A (ru) 2009-12-27
TW200804375A (en) 2008-01-16

Similar Documents

Publication Publication Date Title
NO20070731L (no) Heterocykliske forbindelser.
NO20075987L (no) Bisykliske derviater som p38-kinaseinhibitorer
NO20076345L (no) Bisykliske derivater som P38-kinaseinhibitorer
NO20053647L (no) Pyrazolopyridinderivater
NO20082105L (no) Pyrazoloisokinolinderivater
MX2009010595A (es) Derivados de pirrolopirimidina.
NO20081003L (no) 2-Aminopyrimidinderivater som modulatorer av histamin-H4-reseptoraktivitet
EA201100875A1 (ru) Новые пиразол-4-n-алкоксикарбоксамиды в качестве микробиоцидов
MX2009007302A (es) Derivados de purina.
BR0313330A (pt) Piperidina-ftalazonas substituìdas com pirrolidinadiona como inibidores de pde4
EA201000269A1 (ru) Новые гербициды
MX2009009774A (es) Derivados de quinolina como fungicidas.
EA200801428A1 (ru) Производные пиридиазинона для лечения опухолей
EA200901609A1 (ru) Амиды пиразолкарбоновой кислоты, применимые в качестве микробиоцидов
MX2010001364A (es) Derivados de ciclopentandiona puenteados triciclicos como herbicidas.
UA103625C2 (en) 5-hetrocyclylalkyl-3-hydroxy-2-phenylcyclopent-2-enons as herbicides
EA201000395A1 (ru) Фунгицидные производные 2-алкилтио-2-хинолинилоксиацетамида
EA200701396A1 (ru) Триазолофталазины в качестве ингибиторов pde-2
NO20075275L (no) Nye forbindelser
TW200637837A (en) Fungicides
UA106880C2 (uk) Нові гербіциди
WO2008151828A8 (en) Novel microbiocides
ATE553106T1 (de) Heteroarylpyrrolopyridinone als kinaseinhibitoren
EA201001348A1 (ru) Пирролопиримидинкарбоксамиды
MX2008001538A (es) Aril piridinas y metodos para su uso.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application